Incidence of Long-Term Pulmonary Vein Reconnection after a 2-Minute Cryoballoon Freeze for Pulmonary Vein Isolation-Invasive Insights of TTI-Dependent Cryoenergy Titration.

PV reconnection atrial fibrillation cryoballoon PVI freeze duration time-to-isolation

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
23 Aug 2022
Historique:
received: 06 05 2022
revised: 02 08 2022
accepted: 03 08 2022
entrez: 22 9 2022
pubmed: 23 9 2022
medline: 23 9 2022
Statut: epublish

Résumé

The optimal freeze duration in cryoballoon pulmonary vein isolation (PVI) is unknown. TTI-based titration of cryoenergy allows individualized freeze duration and has emerged as a favorable ablation strategy in PV cryoablation. In a recent study, we demonstrated that omission of a bonus freeze and reduction in freeze duration to a minimum of 2 min in the case of short TTI led to comparable arrhythmia recurrence rates. Whereas clinical outcome seems to be comparable to fixed freeze duration, evidence of long-term PV reconnection rates in patients undergoing TTI-based cryoballoon ablation is sparse. To evaluate the procedural efficacy of a single 2-min freeze for PVI, we assessed PV conduction recovery after cryoballoon PVI with a TTI-guided titration of freeze duration compared to a fixed ablation protocol. We included consecutive patients with atrial fibrillation (AF) recurrence undergoing a second ablation procedure after the initial cryoballoon procedure. The second AF ablation procedure was performed by the 3D-mapping system and radiofrequency ablation technique. A total of 219 patients (age: 66.2 ± 10.8 years, 53% female, paroxysmal AF: 53%) treated with the TTI-guided protocol (174 patients, 685 PV) or fixed protocol (45 patients, 179 PV) showed comparable total reconnection rates (TTI: 36.9% vs. fixed: 31.8%, overall reconnection rate was not different using a TTI-guided ablation protocol compared to a fixed ablation protocol, whereas the LIPV reconnection rate was significantly lower in patients treated with a fixed ablation protocol.

Identifiants

pubmed: 36135429
pii: jcdd9090284
doi: 10.3390/jcdd9090284
pmc: PMC9505807
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

A.P. is an invited fellow of the Boston Scientific EP Fellowship. A.P. and T.D. received speaker’s honoraria from Medtronic, Biosense Webster, Bayer, Daiichi and Pfizer.

Références

Circ Arrhythm Electrophysiol. 2019 May 22;12(6):e007247
pubmed: 31693319
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):288-92
pubmed: 24610797
J Am Coll Cardiol. 2021 Aug 31;78(9):914-930
pubmed: 34446164
Europace. 2014 May;16(5):639-44
pubmed: 24478116
J Cardiol. 2017 Jan;69(1):24-29
pubmed: 27650097
ESC Heart Fail. 2020 Oct;7(5):2258-2267
pubmed: 32578969
Int J Cardiol. 2021 Oct 1;340:34-35
pubmed: 34343530
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):293-9
pubmed: 24610739
JACC Clin Electrophysiol. 2019 May;5(5):551-559
pubmed: 31122376
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Heart Vessels. 2018 Sep;33(9):1052-1059
pubmed: 29464341
N Engl J Med. 2016 Jun 9;374(23):2235-45
pubmed: 27042964
Int J Cardiol. 2018 Mar 15;255:80-84
pubmed: 29425568
BMC Cardiovasc Disord. 2020 Apr 23;20(1):197
pubmed: 32326885
Clin Res Cardiol. 2016 Sep;105(9):774-82
pubmed: 27085722
J Interv Card Electrophysiol. 2016 Dec;47(3):341-348
pubmed: 27475949
J Cardiovasc Electrophysiol. 2014 Aug;25(8):834-839
pubmed: 24641307
Heart Rhythm. 2017 Apr;14(4):495-500
pubmed: 27956248
Arq Bras Cardiol. 2021 Jul;117(1):100-105
pubmed: 34320077
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1088-94
pubmed: 26338833
Cardiol J. 2019;26(4):368-374
pubmed: 29924380
J Cardiovasc Electrophysiol. 2014 Aug;25(8):840-844
pubmed: 24654794
Indian Pacing Electrophysiol J. 2019 Jul - Aug;19(4):129-133
pubmed: 30796960

Auteurs

Alexander Pott (A)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Michael Baumhardt (M)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Mohammad Al-Masalmeh (M)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Alexander Wolf (A)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Matthias Schiele (M)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Christiane Schweizer (C)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Carlo Bothner (C)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Deniz Aktolga (D)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Yannick Teumer (Y)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Karolina Weinmann (K)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Wolfgang Rottbauer (W)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Tillman Dahme (T)

Department of Medicine II, Ulm University Medical Center, 89073 Ulm, Germany.

Classifications MeSH